Japanese pharma companies forecast to have 17% growth in 2017 (Pharmabiz April 21, 2017)
(Copyright © 2016 Saffron Media Pvt. Ltd)
Japanese pharma companies forecast to have 17% growth in 2017
CPhI Japan – organised by UBM EMEA and UBM Asia – returned to Tokyo for its 16th edition from April 19-21, 2017, with the release of new research into the Japanese pharmaceutical market. Over 90 domestic and international companies attending the event were surveyed to provide a holistic picture of the country’s best growth opportunities. Overall, domestic companies in Japan are forecasting a staggering 17 per cent growth in 2017 – highlighting renewed buoyancy in the Japanese pharmaceutical economy following several years of limited growth.